Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia
出版年份 2023 全文链接
标题
Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia
作者
关键词
-
出版物
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 37, Issue 4, Pages e1-e13
出版商
Elsevier BV
发表日期
2023-08-12
DOI
10.1016/j.hoc.2023.06.012
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
- (2022) David F. Moreno et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
- (2021) Sabrin Tahri et al. Blood Advances
- Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
- (2020) Steven P. Treon et al. JOURNAL OF CLINICAL ONCOLOGY
- Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management
- (2020) Morie A. Gertz AMERICAN JOURNAL OF HEMATOLOGY
- CXCR4 in Waldenström’s Macroglobulinema: chances and challenges
- (2020) Lisa Marie Kaiser et al. LEUKEMIA
- Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia
- (2019) Mark Bustoros et al. JOURNAL OF CLINICAL ONCOLOGY
- How I treat Waldenström's Macroglobulinemia
- (2019) Meletios A Dimopoulos et al. BLOOD
- Validation and further potentialities of the novel AWM score for progression risk stratification in patients with asymptomatic Waldenström macroglobulinemia
- (2019) Michele Merli et al. LEUKEMIA & LYMPHOMA
- Impact of MYD88 L265P mutation status on histological transformation of Waldenström Macroglobulinemia
- (2019) Saurabh Zanwar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States
- (2018) Priyanka A. Pophali et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYD88 mutated and wild-type Waldenströms Macroglobulinemia: Characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4.
- (2018) Maria Luisa Guerrera et al. HAEMATOLOGICA
- MYD88 mutated and wild-type Waldenströms Macroglobulinemia: Characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4.
- (2018) Maria Luisa Guerrera et al. HAEMATOLOGICA
- Diagnosis and Management of Waldenström Macroglobulinemia
- (2017) Prashant Kapoor et al. JAMA Oncology
- Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
- (2016) Zachary R. Hunter et al. BLOOD
- Treatment recommendations from the Eighth International Workshop on Waldenstroms Macroglobulinemia
- (2016) V. Leblond et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Familial predisposition and genetic risk factors for lymphoma
- (2015) J. R. Cerhan et al. BLOOD
- Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia
- (2015) Lian Xu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Extramedullary Waldenström macroglobulinemia
- (2014) Ranjit Banwait et al. AMERICAN JOURNAL OF HEMATOLOGY
- Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia
- (2014) S. P. Treon et al. BLOOD
- Survival trends in Waldenstrom macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database
- (2014) J. J. Castillo et al. BLOOD
- Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies
- (2014) Marzia Varettoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
- (2014) L Xu et al. LEUKEMIA
- MYD88 L265P mutation in Waldenstrom macroglobulinemia
- (2013) S. Poulain et al. BLOOD
- The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
- (2013) Z. R. Hunter et al. BLOOD
- Progression in smoldering Waldenstrom macroglobulinemia: long-term results
- (2012) R. A. Kyle et al. BLOOD
- Factors Predicting Transformation of Asymptomatic IgM Monoclonal Gammopathy
- (2012) Antonino Greco et al. Clinical Lymphoma Myeloma & Leukemia
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started